Warning letters, 483s, Recalls, Import Alerts, Audit observations
Breckenridge Pharmaceutical Inc. has announced the recall of over 360,000 bottles of Duloxetine Delayed-Release Capsules
WHO has published a comprehensive and easy to understand guideline for control of nitrosamines in
With timelines closing in for drug product manufacturers to finalize their nitrosamine risk assessments, recalls
Authored by: Venkiteswaran.T.K Nitrosamine impurities in pharmaceutical products are a significant concern due to their
Glenmark Pharmaceuticals has initiated a recall of over 1.5 million bottles of their ADHD medication,
Glenmark Pharmaceuticals is recalling several lots of the cardiovascular drug Carvedilol in US due to
Adding to the growing number of drug recalls due to NDSRIs in 2024, Glenmark is
Adding to the number of recalls during 2024 for NDSRIs, Ascend (Alkem) is recalling the
Aurobindo is recalling Cinacalcet tablets in US due to nitrosamine NDSRI impurity N-Nitroso-cinacalcet. Aurobindo has
Several lots of the antidepressant drug Duloxetine, manufactured by Aurobindo, India, have been recalled in
